Fulcrum Therapeutics
FULC
FULC
110 hedge funds and large institutions have $366M invested in Fulcrum Therapeutics in 2022 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 47 increasing their positions, 25 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
5.85% less ownership
Funds ownership: 103.13% → 97.28% (-5.8%)
13% less capital invested
Capital invested by funds: $422M → $366M (-$56.5M)
Holders
110
Holding in Top 10
2
Calls
$4.21M
Puts
$380K
Top Buyers
| 1 | +$18.2M | |
| 2 | +$7.33M | |
| 3 | +$5.44M | |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$3.64M |
| 5 |
BlackRock
New York
|
+$3.62M |
Top Sellers
| 1 | -$18.7M | |
| 2 | -$14.6M | |
| 3 | -$12.1M | |
| 4 |
CAC
Cowen and Company
New York
|
-$7.18M |
| 5 |
VA
VR Adviser
New York
|
-$5.48M |